Physician profile
Thida Myint
NPI 1447817051
$693.14
in general payments reported to CMS, 2019-2025
7 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.32 · 2022: $223 · 2023: $215 · 2024: $55.66 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $196.44 | 2021-2023 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $166.11 | 2022-2024 | Hemosphere |
| Heron Therapeutics, INC. | $163.18 | 2021-2023 | Aponvie |
| Conmed Corporation | $100.45 | 2025 | Airseal |
| La Jolla Pharmaceutical Company | $36.82 | 2022 | |
| Amgen INC. | $16.69 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.45 | 2023 | Fasenra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thida Myint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.